Overview
No overview information available.
Indication
用于既往接受过至少两种系统性治疗的复发或难治滤泡性淋巴瘤成人患者。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/06/22 | Phase 2 | Not yet recruiting | |||
2024/12/02 | Phase 1 | Not yet recruiting | |||
2024/09/11 | Phase 1 | Recruiting | |||
2024/08/12 | Phase 2 | Not yet recruiting | |||
2024/07/08 | Phase 2 | Recruiting | |||
2024/05/20 | Phase 1 | Recruiting | Yanyan Liu | ||
2024/04/19 | Phase 1 | Recruiting | Beijing Tongren Hospital | ||
2024/04/04 | Phase 2 | Recruiting | Peking University | ||
2024/04/03 | Phase 4 | Not yet recruiting | |||
2024/03/22 | Phase 2 | Not yet recruiting | Dalian Medical University |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Linperlisib Tablets | 国药准字H20220030 | 化学药品 | 片剂 | 11/8/2022 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.